Metabolism of vasoactive substances in the lung.
D006916:5-Hydroxytryptophan / Q000378:metabolism; D000227:Adenine Nucleotides / Q000378:metabolism; D000241:Adenosine / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D066298:In Vitro Techniques; D008168:Lung / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010477:Perfusion; D011119:Polynucleotides / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D011652:Pulmonary Circulation / Q000187:drug effects; D011817:Rabbits; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D014667:Vasopressins / Q000378:metabolism
D000227:Adenine Nucleotides; D011119:Polynucleotides; D011453:Prostaglandins; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D000804:Angiotensin II; D000255:Adenosine Triphosphate; D006916:5-Hydroxytryptophan; D000241:Adenosine; D001920:Bradykinin; D009638:Norepinephrine; D004837:Epinephrine